Coave Therapeutics to Present at Upcoming Conferences
Coave Therapeutics to Present at Upcoming Conferences
Paris, France, March 27, 2024 – Coave Therapeutics (‘Coave’), a genetic medicine company focused on developing life-changing therapies, announces that its management will be attending the following upcoming investor and industry conferences:
- Cell & Gene Meeting on the Med – April 9-11 ; Rome, Italy
Company Presentation by CEO Rodolphe Clerval on April 10 at 13.45 CET
- LSX World Congress – April 29-30 ; London, UK
CEO Rodolphe Clerval attending and available for investor meetings
- BioEquity Europe – May 12-24 ; San Sebastián, Spain
Company Presentation by CEO Rodolphe Clerval - Date/Time TBC
- Gene Therapy Analytical Development Europe Summit - May 22-24 ; London, UK
Presentation by COO Patricia Françon on May 24 at 10.00 BST
- ARVO (Association for Research in Vision and Ophthalmology) - May 5-6 ; Seattle, WA, US
- ASGCT (American Society of Gene and Cell Therapy) - May 7-11 ; Baltimore, MD, US
Editor Details
-
Name:
- pharmiweb